CorMedix Inc [NASDAQ: CRMD] price plunged by -31.85 percent to reach at -$3.43.
The one-year CRMD stock forecast points to a potential upside of 54.52. The average equity rating for CRMD stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on CorMedix Inc [CRMD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CRMD shares is $16.14 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CRMD stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for CorMedix Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 07, 2025. While these analysts kept the previous recommendation, D. Boral Capital raised their target price to Buy. The new note on the price target was released on January 13, 2025, representing the official price target for CorMedix Inc stock. Previously, the target price had yet another raise to $13, while Rodman & Renshaw analysts kept a Buy rating on CRMD stock.
The Average True Range (ATR) for CorMedix Inc is set at 0.85, with the Price to Sales ratio for CRMD stock in the period of the last 12 months amounting to 36.33. The Price to Book ratio for the last quarter was 7.24, with the Price to Cash per share for the same quarter was set at 0.76.
CRMD Stock Performance Analysis:
CorMedix Inc [CRMD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -29.63. With this latest performance, CRMD shares dropped by -27.33% in over the last four-week period, additionally sinking by -0.54% over the last 6 months – not to mention a rise of 88.21% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CRMD stock in for the last two-week period is set at 27.41, with the RSI for the last a single of trading hit 20.20, and the three-weeks RSI is set at 32.65 for CorMedix Inc [CRMD]. The present Moving Average for the last 50 days of trading for this stock 10.75, while it was recorded at 10.17 for the last single week of trading, and 8.27 for the last 200 days.
Insight into CorMedix Inc Fundamentals:
CorMedix Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.60 and a Current Ratio set at 3.96.
CorMedix Inc [CRMD] Institutonal Ownership Details
There are presently around $39.99%, or 40.50%% of CRMD stock, in the hands of institutional investors. The top three institutional holders of CRMD stocks are: BLACKROCK INC. with ownership of 3.55 million shares, which is approximately 6.167%. VANGUARD GROUP INC, holding 2.9 million shares of the stock with an approximate value of $$12.57 million in CRMD stocks shares; and VANGUARD GROUP INC, currently with $$6.71 million in CRMD stock with ownership which is approximately 2.6909%.
